首页 > 最新文献

Cancer Control最新文献

英文 中文
Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study. 接受放疗的非小细胞肺癌非手术脑转移患者的生存预测提名图:基于人群的研究
IF 2.6 4区 医学 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1177/10732748241255212
Peng Li, Jie Luo, Zilong Zheng, Lu Meng, Anqi Zhang, Wei Cao, Xiaomei Gong

Objective: A high number of Non-Small Cell Lung Cancer (NSCLC) patients with brain metastasis who have not had surgery often have a negative outlook. Radiotherapy remains a most common and effective method. Nomograms were developed to forecast the cancer-specific survival (CSS) and overall survival (OS) in NSCLC individuals with nonoperative brain metastases who underwent radiotherapy.

Methods: Information was gathered from the Surveillance, Epidemiology, and End Results (SEER) database about patients diagnosed with NSCLC who had brain metastases not suitable for surgery. Nomograms were created and tested using multivariate Cox regression models to forecast CSS and OS at intervals of 1, 2, and 3 years.

Results: The research involved 3413 individuals diagnosed with NSCLC brain metastases who had undergone radiotherapy but had not experienced surgery. These participants were randomly divided into two categories. The analysis revealed that gender, age, ethnicity, marital status, tumor location, tumor laterality, tumor grade, histology, T stage, N stage, chemotherapy, tumor size, lung metastasis, bone metastasis, and liver metastasis were significant independent predictors for OS and CSS. The C-index for the training set for predicting OS was .709 (95% CI, .697-.721), and for the validation set, it was .705 (95% CI, .686-.723), respectively. The C-index for predicting CSS was .710 (95% CI, .697-.722) in the training set and .703 (95% CI, .684-.722) in the validation set, respectively. The nomograms model, as suggested by the impressive C-index, exhibits outstanding differentiation ability. Moreover, the ROC and calibration curves reveal its commendable precision and distinguishing potential.

Conclusions: For the first time, highly accurate and reliable nomograms were developed to predict OS and CSS in NSCLC patients with non-surgical brain metastases, who have undergone radiotherapy treatment. The nomograms may assist in tailoring counseling strategies and choosing the most effective treatment method.

目的:大量非小细胞肺癌(NSCLC)脑转移患者如果没有接受手术治疗,其前景往往不容乐观。放疗仍然是最常用、最有效的方法。本研究开发了预测接受放疗的非手术脑转移 NSCLC 患者癌症特异性生存率(CSS)和总生存率(OS)的提名图:方法:从监测、流行病学和最终结果(SEER)数据库中收集被诊断为不适合手术的脑转移瘤 NSCLC 患者的信息。使用多变量考克斯回归模型创建并测试了预测1年、2年和3年间隔期CSS和OS的提名图:研究涉及 3413 名确诊为 NSCLC 脑转移患者,这些患者接受过放疗,但未进行过手术。这些参与者被随机分为两类。分析显示,性别、年龄、种族、婚姻状况、肿瘤位置、肿瘤侧位、肿瘤分级、组织学、T期、N期、化疗、肿瘤大小、肺转移、骨转移和肝转移是OS和CSS的重要独立预测因素。训练集预测OS的C指数为0.709(95% CI,0.697-0.721),验证集预测OS的C指数为0.705(95% CI,0.686-0.723)。在训练集和验证集中,预测 CSS 的 C 指数分别为 0.710(95% CI,0.697-0.722)和 0.703(95% CI,0.684-0.722)。令人印象深刻的 C 指数表明,提名图模型具有出色的区分能力。此外,ROC 和校准曲线也显示了其值得称道的精确度和区分潜力:该研究首次开发出高度准确可靠的提名图,用于预测接受放疗的非手术脑转移 NSCLC 患者的 OS 和 CSS。该提名图有助于制定咨询策略和选择最有效的治疗方法。
{"title":"Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung Cancer Receiving Radiotherapy: A Population-Based Study.","authors":"Peng Li, Jie Luo, Zilong Zheng, Lu Meng, Anqi Zhang, Wei Cao, Xiaomei Gong","doi":"10.1177/10732748241255212","DOIUrl":"10.1177/10732748241255212","url":null,"abstract":"<p><strong>Objective: </strong>A high number of Non-Small Cell Lung Cancer (NSCLC) patients with brain metastasis who have not had surgery often have a negative outlook. Radiotherapy remains a most common and effective method. Nomograms were developed to forecast the cancer-specific survival (CSS) and overall survival (OS) in NSCLC individuals with nonoperative brain metastases who underwent radiotherapy.</p><p><strong>Methods: </strong>Information was gathered from the Surveillance, Epidemiology, and End Results (SEER) database about patients diagnosed with NSCLC who had brain metastases not suitable for surgery. Nomograms were created and tested using multivariate Cox regression models to forecast CSS and OS at intervals of 1, 2, and 3 years.</p><p><strong>Results: </strong>The research involved 3413 individuals diagnosed with NSCLC brain metastases who had undergone radiotherapy but had not experienced surgery. These participants were randomly divided into two categories. The analysis revealed that gender, age, ethnicity, marital status, tumor location, tumor laterality, tumor grade, histology, T stage, N stage, chemotherapy, tumor size, lung metastasis, bone metastasis, and liver metastasis were significant independent predictors for OS and CSS. The C-index for the training set for predicting OS was .709 (95% CI, .697-.721), and for the validation set, it was .705 (95% CI, .686-.723), respectively. The C-index for predicting CSS was .710 (95% CI, .697-.722) in the training set and .703 (95% CI, .684-.722) in the validation set, respectively. The nomograms model, as suggested by the impressive C-index, exhibits outstanding differentiation ability. Moreover, the ROC and calibration curves reveal its commendable precision and distinguishing potential.</p><p><strong>Conclusions: </strong>For the first time, highly accurate and reliable nomograms were developed to predict OS and CSS in NSCLC patients with non-surgical brain metastases, who have undergone radiotherapy treatment. The nomograms may assist in tailoring counseling strategies and choosing the most effective treatment method.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11110521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141071416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Narrative Review of the Current Research in Cancer-Related Pain Inequities: The Necessity of Applying Intersectionality to Advance Cancer Pain Research. 癌症相关疼痛不公平现象研究现状综述》:应用交叉性推进癌症疼痛研究的必要性》。
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241274256
Katarina E AuBuchon, Myla Lyons, Erika Braun, Hunter Groninger, Kristi Graves, Lisa Bowleg

Cancer-related pain has a significant impact on quality of life for patients with cancer. In populations without cancer, there are documented pain inequities associated with minoritized racial and/or ethnic groups, women, and low socioeconomic status. However, our understanding of pain inequities specifically among patients with cancer remains incomplete. We narratively synthesized published quantitative research on cancer-related pain inequities in the US in the past decade. A search identified 17 English-language articles examining pain for patients with various cancer types at different treatment stages. Our review revealed mixed findings comparing cancer-related pain by racial group (e.g., Black vs White) and sex (male vs female), but consistent findings indicating that people with lower (vs higher) socioeconomic status and younger (vs older) patients report more cancer-related pain. Research on cancer pain among sexual and gender minorities remains scant. Key research gaps include a need for more research that incorporates an intersectional perspective by exploring intersecting subgroups and measuring social and structural processes that drive pain inequities. These findings underscore an important need for researchers to use an intersectional approach to cancer pain to help elucidate key populations at-risk for exacerbated cancer-related pain and identify ways to mitigate social and structural processes that drive these inequities.

癌症相关疼痛对癌症患者的生活质量有很大影响。在未患癌症的人群中,有记录表明疼痛与少数种族和/或民族群体、女性和社会经济地位低下有关。然而,我们对癌症患者疼痛不公平现象的了解仍不全面。我们对过去十年美国已发表的有关癌症相关疼痛不平等的定量研究进行了叙述性综合。通过检索,我们发现了 17 篇研究不同癌症类型患者在不同治疗阶段疼痛情况的英文文章。我们的综述显示,按种族群体(如黑人与白人)和性别(男性与女性)比较癌症相关疼痛的结果不一,但一致的结果表明,社会经济地位较低(与较高)的人和较年轻(与较年长)的病人报告的癌症相关疼痛较多。有关性少数群体和性别少数群体癌症疼痛的研究仍然很少。主要的研究缺口包括需要进行更多的研究,通过探索相互交叉的亚群体并测量导致疼痛不平等的社会和结构过程,从而纳入交叉视角。这些发现强调了研究人员的一个重要需求,即使用交叉方法来研究癌症疼痛,以帮助阐明癌症相关疼痛加剧的主要高危人群,并确定减轻导致这些不平等的社会和结构过程的方法。
{"title":"A Narrative Review of the Current Research in Cancer-Related Pain Inequities: The Necessity of Applying Intersectionality to Advance Cancer Pain Research.","authors":"Katarina E AuBuchon, Myla Lyons, Erika Braun, Hunter Groninger, Kristi Graves, Lisa Bowleg","doi":"10.1177/10732748241274256","DOIUrl":"10.1177/10732748241274256","url":null,"abstract":"<p><p>Cancer-related pain has a significant impact on quality of life for patients with cancer. In populations without cancer, there are documented pain inequities associated with minoritized racial and/or ethnic groups, women, and low socioeconomic status. However, our understanding of pain inequities specifically among patients with cancer remains incomplete. We narratively synthesized published quantitative research on cancer-related pain inequities in the US in the past decade. A search identified 17 English-language articles examining pain for patients with various cancer types at different treatment stages. Our review revealed mixed findings comparing cancer-related pain by racial group (e.g., Black vs White) and sex (male vs female), but consistent findings indicating that people with lower (vs higher) socioeconomic status and younger (vs older) patients report more cancer-related pain. Research on cancer pain among sexual and gender minorities remains scant. Key research gaps include a need for more research that incorporates an intersectional perspective by exploring intersecting subgroups and measuring social and structural processes that drive pain inequities. These findings underscore an important need for researchers to use an intersectional approach to cancer pain to help elucidate key populations at-risk for exacerbated cancer-related pain and identify ways to mitigate social and structural processes that drive these inequities.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis. 宫颈癌患者 3 年和 5 年相对生存率的评估和预测分析:基于模型的周期分析
IF 2.6 4区 医学 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1177/10732748241232324
Xiaodong Fan, Wei He, Qing Zhang, Binjie Zhang, Li Dong, Li Li, Xiaochun Liu

Background: Cervical cancer remains a threat to female health due to high mortality. Clarification of the long-term trend of survival rate over time and the associated risk factors would be greatly informative to improve the prognosis of cervical cancer patients.

Methods: This retrospective study was based on data extracted from the Surveillance, Epidemiology, and End Results (SEER) database of the United States. The 3-year and 5-year overall survival rates of patients with cervical cancer during 2002-2006, 2007-2011, and 2012-2016 were analyzed. Period analysis was used to assess the variation in survival rate stratified by age, race, and socioeconomic status during the 15-year study period and then predicted the relative survival rate in the following period from 2017 to 2021.

Results: During 2002-2016, the 3-year relative survival rate of cervical cancer patients increased from 73.1% to 73.5% with a high jump between 2007 and 2011. This upward trend is expected to continue to 74.3% between 2017 and 2021. Patients older than 60 years, black ethnicity, or medium and high poverty status were likely to have a lower relative survival rate.

Conclusion: This study confirmed the increased relative survival rate of cervical cancer patients over years and identified relevant risk factors. Targeted initiatives for elderly and socially underprivileged individuals may be able to mitigate inequality.

背景:宫颈癌因其死亡率高而一直威胁着女性健康。厘清宫颈癌患者长期生存率的变化趋势及相关风险因素,对改善宫颈癌患者的预后大有裨益:这项回顾性研究基于从美国监测、流行病学和最终结果(SEER)数据库中提取的数据。研究分析了2002-2006年、2007-2011年和2012-2016年期间宫颈癌患者的3年和5年总生存率。采用周期分析法评估了15年研究期间按年龄、种族和社会经济状况分层的生存率变化,然后预测了2017年至2021年期间的相对生存率:2002-2016年期间,宫颈癌患者的3年相对生存率从73.1%上升至73.5%,其中2007年至2011年期间出现了大幅跃升。预计在 2017 年至 2021 年期间,这一上升趋势将持续到 74.3%。60岁以上、黑人或中度和高度贫困患者的相对生存率可能较低:这项研究证实,宫颈癌患者的相对生存率逐年上升,并确定了相关的风险因素。针对老年人和社会弱势群体的针对性措施或许能缓解不平等现象。
{"title":"Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.","authors":"Xiaodong Fan, Wei He, Qing Zhang, Binjie Zhang, Li Dong, Li Li, Xiaochun Liu","doi":"10.1177/10732748241232324","DOIUrl":"10.1177/10732748241232324","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer remains a threat to female health due to high mortality. Clarification of the long-term trend of survival rate over time and the associated risk factors would be greatly informative to improve the prognosis of cervical cancer patients.</p><p><strong>Methods: </strong>This retrospective study was based on data extracted from the Surveillance, Epidemiology, and End Results (SEER) database of the United States. The 3-year and 5-year overall survival rates of patients with cervical cancer during 2002-2006, 2007-2011, and 2012-2016 were analyzed. Period analysis was used to assess the variation in survival rate stratified by age, race, and socioeconomic status during the 15-year study period and then predicted the relative survival rate in the following period from 2017 to 2021.</p><p><strong>Results: </strong>During 2002-2016, the 3-year relative survival rate of cervical cancer patients increased from 73.1% to 73.5% with a high jump between 2007 and 2011. This upward trend is expected to continue to 74.3% between 2017 and 2021. Patients older than 60 years, black ethnicity, or medium and high poverty status were likely to have a lower relative survival rate.</p><p><strong>Conclusion: </strong>This study confirmed the increased relative survival rate of cervical cancer patients over years and identified relevant risk factors. Targeted initiatives for elderly and socially underprivileged individuals may be able to mitigate inequality.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10898299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139974084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-Energy Computed Tomography Parameters Combined With Inflammatory Indicators Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. 双能量计算机断层扫描参数结合炎症指标预测甲状腺乳头状癌的颈淋巴结转移
IF 2.6 4区 医学 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1177/10732748241262177
Longyu Wei, Yaoyuan Wu, Juan Bo, Baoyue Fu, Mingjie Sun, Yu Zhang, Baizhu Xiong, Jiangning Dong

Background and objective: Cervical lymph node metastasis (CLNM) is considered a marker of papillar Fethicy thyroid cancer (PTC) progression and has a potential impact on the prognosis of PTC. The purpose of this study was to screen for predictors of CLNM in PTC and to construct a predictive model to guide the surgical approach in patients with PTC.

Methods: This is a retrospective study. Preoperative dual-energy computed tomography images of 114 patients with pathologically confirmed PTC between July 2019 and April 2023 were retrospectively analyzed. The dual-energy computed tomography parameters [iodine concentration (IC), normalized iodine concentration (NIC), the slope of energy spectrum curve (λHU)] of the venous stage cancer foci were measured and calculated. The independent influencing factors for predicting CLNM were determined by univariate and multivariate logistic regression analysis, and the prediction models were constructed. The clinical benefits of the model were evaluated using decision curves, calibration curves, and receiver operating characteristic curves.

Results: The statistical results show that NIC, derived neutrophil-to-lymphocyte ratio (dNLR), prognostic nutritional index (PNI), gender, and tumor diameter were independent predictors of CLNM in PTC. The AUC of the nomogram was .898 (95% CI: .829-.966), and the calibration curve and decision curve showed that the prediction model had good predictive effect and clinical benefit, respectively.

Conclusion: The nomogram constructed based on dual-energy CT parameters and inflammatory prognostic indicators has high clinical value in predicting CLNM in PTC patients.

背景和目的:宫颈淋巴结转移(CLNM)被认为是乳头状费氏甲状腺癌(PTC)进展的标志物,对PTC的预后有潜在影响。本研究的目的是筛查PTC中CLNM的预测因子,并构建一个预测模型来指导PTC患者的手术方法:这是一项回顾性研究。回顾性分析了2019年7月至2023年4月期间114例经病理确诊的PTC患者的术前双能计算机断层扫描图像。测量并计算了静脉期癌灶的双能计算机断层扫描参数[碘浓度(IC)、归一化碘浓度(NIC)、能谱曲线斜率(λHU)]。通过单变量和多变量逻辑回归分析确定了预测 CLNM 的独立影响因素,并构建了预测模型。利用决策曲线、校正曲线和接收者操作特征曲线评估了模型的临床效益:统计结果显示,中性粒细胞比(NIC)、衍生中性粒细胞与淋巴细胞比(dNLR)、预后营养指数(PNI)、性别和肿瘤直径是 PTC CLNM 的独立预测因子。提名图的AUC为0.898(95% CI:0.829-0.966),校准曲线和决策曲线分别显示该预测模型具有良好的预测效果和临床效益:基于双能 CT 参数和炎症预后指标构建的提名图在预测 PTC 患者的 CLNM 方面具有较高的临床价值。
{"title":"Dual-Energy Computed Tomography Parameters Combined With Inflammatory Indicators Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.","authors":"Longyu Wei, Yaoyuan Wu, Juan Bo, Baoyue Fu, Mingjie Sun, Yu Zhang, Baizhu Xiong, Jiangning Dong","doi":"10.1177/10732748241262177","DOIUrl":"10.1177/10732748241262177","url":null,"abstract":"<p><strong>Background and objective: </strong>Cervical lymph node metastasis (CLNM) is considered a marker of papillar Fethicy thyroid cancer (PTC) progression and has a potential impact on the prognosis of PTC. The purpose of this study was to screen for predictors of CLNM in PTC and to construct a predictive model to guide the surgical approach in patients with PTC.</p><p><strong>Methods: </strong>This is a retrospective study. Preoperative dual-energy computed tomography images of 114 patients with pathologically confirmed PTC between July 2019 and April 2023 were retrospectively analyzed. The dual-energy computed tomography parameters [iodine concentration (IC), normalized iodine concentration (NIC), the slope of energy spectrum curve (λ<sub>HU</sub>)] of the venous stage cancer foci were measured and calculated. The independent influencing factors for predicting CLNM were determined by univariate and multivariate logistic regression analysis, and the prediction models were constructed. The clinical benefits of the model were evaluated using decision curves, calibration curves, and receiver operating characteristic curves.</p><p><strong>Results: </strong>The statistical results show that NIC, derived neutrophil-to-lymphocyte ratio (dNLR), prognostic nutritional index (PNI), gender, and tumor diameter were independent predictors of CLNM in PTC. The AUC of the nomogram was .898 (95% CI: .829-.966), and the calibration curve and decision curve showed that the prediction model had good predictive effect and clinical benefit, respectively.</p><p><strong>Conclusion: </strong>The nomogram constructed based on dual-energy CT parameters and inflammatory prognostic indicators has high clinical value in predicting CLNM in PTC patients.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11181884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy. 使用非适应性磁共振引导放疗的前列腺 SBRT 临床疗效。
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241270595
Maria L Sandoval, Anupam Rishi, Kujtim Latifi, G Daniel Grass, Javier Torres-Roca, Stephen A Rosenberg, Kosj Yamoah, Peter A S Johnstone
<p><strong>Objectives: </strong>Stereotactic body radiotherapy (SBRT) is widely used for localized prostate cancer and implementation of MR-guided radiotherapy has the advantage of tighter margins and improved sparing of organs at risk. Here we evaluate outcomes and time required to treat using non-adaptive MR-guided SBRT (MRgSBRT) for localized prostate cancer at our institution.</p><p><strong>Methods: </strong>From 9/2019 to 11/2021 we conducted a retrospective review of 80 consecutive patients who were treated with MRgSBRT to the prostate. Patients included low (LR) (5%), favorable intermediate (FIR) (40%), unfavorable intermediate (UIR) (49%), and high risk (HR) (6%). Short-term androgen deprivation therapy was used in 32% of patients. Target volumes included prostate gland and proximal seminal vesicles with an isotropic 3 mm margin. Treatment was prescribed to 36.25 Gy in 5 fractions every other day with urethral sparing. Hydrogel spacer was used in 18% of patients. Time on the linac was recorded as beam on time (BOT) plus total treatment time (TTT) including gating. Analyzed outcomes included PSA response and patient reported outcomes scored by the American Urological Association (AUA) questionnaire and toxicity per CTCAE v5. General linear regression model was used to analyze factors affecting PSA and AUA in longitudinal follow up, and chi-square test was used to assess factors affecting toxicity.</p><p><strong>Results: </strong>Median follow up was 19.3 months (3.8 - 36.6). Median BOT was 4.6 min (2.6 - 7.2) with a median TTT of 11 min (7.6 - 15.8). Pre-treatment vs post-RT median PSA was 6.36 (2.20 - 19.6) vs 0.85 (0.19 - 3.6), respectively (<i>P</i> < 0.001). PSA decrease differed significantly when patients were stratified by risk category, favoring LR/FIR vs UIF/HR group (<i>P</i> = 0.019). Four (5%) patients experienced a biochemical failure (BCF), with a median time to BCF of 20.4 months (7.9 - 34.5). Median biochemical failure free survival (BCFFS) was not reached, with 2-yr and 4-yr BCFFS of 97.1% and 72.1%, respectively. Patients with LR/FIR disease had 100% 2-yr and 4-yr BCFFS, whereas patients with UIF/HR had 95% and 41% 2-yr and 4-yr BCFFS (<i>P</i> = 0.05). Mean pre-treatment AUA was 7.3 (1 - 25) vs 11.3 (1 - 26) at first follow-up; however, AUA normalized to baseline over time. Urethral Dmax ≥35 Gy trended to lower AUA score at all follow-ups (<i>P</i> = 0.07). Forty-one (51%) patients reported grade 1-2 genitourinary toxicities at the 1 month follow up. Grade 3 toxicity (proctitis) was noted in 1 patient. There was no decrease in any grade rectal toxicity with use of hydrogel spacer (3 vs 6, <i>P</i> = 0.2). No grade ≥4 toxicities was observed.</p><p><strong>Conclusions: </strong>MRgSBRT has the potential for treatment adaptation but this comes at the cost of increased resource utilization. Our experience with non-adaptive MRgSBRT of the prostate highlights its short treatment times as well as efficacy with good PSA control
目的:立体定向体放射治疗(SBRT)被广泛应用于前列腺癌的局部治疗,采用磁共振引导放疗的优点是边缘更紧密,能更好地保护危险器官。在此,我们对本机构使用非适应性磁共振引导 SBRT(MRgSBRT)治疗局部前列腺癌的疗效和所需时间进行了评估:从 2019 年 9 月至 2021 年 11 月,我们对连续接受前列腺 MRgSBRT 治疗的 80 例患者进行了回顾性审查。患者包括低危(LR)(5%)、中危(FIR)(40%)、中危(UIR)(49%)和高危(HR)(6%)。32%的患者采用了短期雄激素剥夺疗法。靶区包括前列腺和精囊近端,边缘各向同性为3毫米。治疗剂量为36.25 Gy,每隔一天治疗5次,同时保留尿道。18%的患者使用了水凝胶垫片。直列加速器上的时间记录为光束照射时间(BOT)加上总治疗时间(TTT),包括门控时间。分析结果包括PSA反应、由美国泌尿协会(AUA)问卷评分的患者报告结果以及CTCAE v5规定的毒性。 采用一般线性回归模型分析影响纵向随访中PSA和AUA的因素,采用卡方检验评估影响毒性的因素:中位随访时间为19.3个月(3.8 - 36.6)。中位 BOT 为 4.6 分钟(2.6 - 7.2),中位 TTT 为 11 分钟(7.6 - 15.8)。治疗前与治疗后的中位 PSA 分别为 6.36(2.20 - 19.6)vs 0.85(0.19 - 3.6)(P < 0.001)。按风险类别对患者进行分层后,PSA下降幅度有明显差异,LR/FIR组与UIF/HR组更有利(P = 0.019)。4例(5%)患者出现生化失败(BCF),中位生化失败时间为20.4个月(7.9 - 34.5)。中位无生化失败生存期(BCFFS)未达标,2年和4年的BCFFS分别为97.1%和72.1%。LR/FIR患者的2年和4年无生化失败生存率为100%,而UIF/HR患者的2年和4年无生化失败生存率分别为95%和41%(P = 0.05)。治疗前的平均 AUA 为 7.3(1 - 25),首次随访时为 11.3(1 - 26);但随着时间的推移,AUA 恢复到基线水平。尿道 Dmax ≥35 Gy 的患者在所有随访中的 AUA 评分均呈下降趋势(P = 0.07)。41名(51%)患者在1个月的随访中报告了1-2级泌尿生殖系统毒性。1名患者出现了3级毒性(直肠炎)。使用水凝胶垫片后,任何级别的直肠毒性均未减少(3 vs 6,P = 0.2)。未观察到≥4级毒性:结论:MRgSBRT具有适应治疗的潜力,但这是以增加资源利用率为代价的。我们在前列腺非适应性 MRgSBRT 方面的经验表明,该疗法治疗时间短、疗效好、PSA 控制良好且毒性低。
{"title":"Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy.","authors":"Maria L Sandoval, Anupam Rishi, Kujtim Latifi, G Daniel Grass, Javier Torres-Roca, Stephen A Rosenberg, Kosj Yamoah, Peter A S Johnstone","doi":"10.1177/10732748241270595","DOIUrl":"https://doi.org/10.1177/10732748241270595","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;Stereotactic body radiotherapy (SBRT) is widely used for localized prostate cancer and implementation of MR-guided radiotherapy has the advantage of tighter margins and improved sparing of organs at risk. Here we evaluate outcomes and time required to treat using non-adaptive MR-guided SBRT (MRgSBRT) for localized prostate cancer at our institution.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;From 9/2019 to 11/2021 we conducted a retrospective review of 80 consecutive patients who were treated with MRgSBRT to the prostate. Patients included low (LR) (5%), favorable intermediate (FIR) (40%), unfavorable intermediate (UIR) (49%), and high risk (HR) (6%). Short-term androgen deprivation therapy was used in 32% of patients. Target volumes included prostate gland and proximal seminal vesicles with an isotropic 3 mm margin. Treatment was prescribed to 36.25 Gy in 5 fractions every other day with urethral sparing. Hydrogel spacer was used in 18% of patients. Time on the linac was recorded as beam on time (BOT) plus total treatment time (TTT) including gating. Analyzed outcomes included PSA response and patient reported outcomes scored by the American Urological Association (AUA) questionnaire and toxicity per CTCAE v5. General linear regression model was used to analyze factors affecting PSA and AUA in longitudinal follow up, and chi-square test was used to assess factors affecting toxicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Median follow up was 19.3 months (3.8 - 36.6). Median BOT was 4.6 min (2.6 - 7.2) with a median TTT of 11 min (7.6 - 15.8). Pre-treatment vs post-RT median PSA was 6.36 (2.20 - 19.6) vs 0.85 (0.19 - 3.6), respectively (&lt;i&gt;P&lt;/i&gt; &lt; 0.001). PSA decrease differed significantly when patients were stratified by risk category, favoring LR/FIR vs UIF/HR group (&lt;i&gt;P&lt;/i&gt; = 0.019). Four (5%) patients experienced a biochemical failure (BCF), with a median time to BCF of 20.4 months (7.9 - 34.5). Median biochemical failure free survival (BCFFS) was not reached, with 2-yr and 4-yr BCFFS of 97.1% and 72.1%, respectively. Patients with LR/FIR disease had 100% 2-yr and 4-yr BCFFS, whereas patients with UIF/HR had 95% and 41% 2-yr and 4-yr BCFFS (&lt;i&gt;P&lt;/i&gt; = 0.05). Mean pre-treatment AUA was 7.3 (1 - 25) vs 11.3 (1 - 26) at first follow-up; however, AUA normalized to baseline over time. Urethral Dmax ≥35 Gy trended to lower AUA score at all follow-ups (&lt;i&gt;P&lt;/i&gt; = 0.07). Forty-one (51%) patients reported grade 1-2 genitourinary toxicities at the 1 month follow up. Grade 3 toxicity (proctitis) was noted in 1 patient. There was no decrease in any grade rectal toxicity with use of hydrogel spacer (3 vs 6, &lt;i&gt;P&lt;/i&gt; = 0.2). No grade ≥4 toxicities was observed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;MRgSBRT has the potential for treatment adaptation but this comes at the cost of increased resource utilization. Our experience with non-adaptive MRgSBRT of the prostate highlights its short treatment times as well as efficacy with good PSA control","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer. 整合单细胞RNA-Seq和大容量RNA-Seq,构建与γδT细胞相关的新型人乳头状瘤病毒感染宫颈癌预后特征。
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241274228
Xiaochuan Wang, Yichao Jin, Liangheng Xu, Sizhen Tao, Yifei Wu, Chunping Ao

Background: Gamma delta (γδ) T cells play dual roles in human tumors, with both antitumor and tumor-promoting functions. However, the role of γδT cells in HPV-infected cervical cancer is still undetermined. Therefore, we aimed to identify γδT cell-related prognostic signatures in the cervical tumor microenvironment.

Methods: Single-cell RNA-sequencing (scRNA-seq) data, bulk RNA-seq data, and corresponding clinical information of cervical cancer patients were obtained from the TCGA and GEO databases. The Seurat R package was used for single-cell analysis, and machine learning algorithms were used to screen and construct a γδT cell-related prognostic signature. Real-time quantitative PCR (RT-qPCR) was performed to detect the expression of prognostic signature genes.

Results: Single-cell analysis indicated distinct populations of γδT cells between HPV-positive (HPV+) and HPV-negative (HPV-) cervical cancers. A trajectory analysis indicated γδT cells clustered into differential clusters with the pseudotime. High-dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA) identified the key γδT cell-related gene modules. Bulk RNA-seq analysis also demonstrated the heterogeneity of immune cells, and the γδT-score was positively associated with inflammatory response and negatively associated with MYC stemness. Eight γδT cell-related hub genes (GTRGs), including ITGAE, IKZF3, LSP1, NEDD9, CLEC2D, RBPJ, TRBC2, and OXNAD1, were selected and validated as a prognostic signature for cervical cancer.

Conclusion: We identified γδT cell-related prognostic signatures that can be considered independent factors for survival prediction in cervical cancer.

背景:γδ(γδ)T 细胞在人类肿瘤中发挥着双重作用,既有抗肿瘤功能,也有促进肿瘤生长的功能。然而,γδT 细胞在人乳头瘤病毒感染的宫颈癌中的作用仍未确定。因此,我们旨在确定宫颈肿瘤微环境中与γδT细胞相关的预后特征:方法:从 TCGA 和 GEO 数据库中获取宫颈癌患者的单细胞 RNA 序列(scRNA-seq)数据、批量 RNA-seq 数据和相应的临床信息。Seurat R软件包用于单细胞分析,机器学习算法用于筛选和构建与γδT细胞相关的预后特征。实时定量 PCR(RT-qPCR)用于检测预后特征基因的表达:结果:单细胞分析表明,HPV 阳性(HPV+)和 HPV 阴性(HPV-)宫颈癌中的γδT 细胞群截然不同。轨迹分析表明,γδT 细胞随假时间聚集成不同的簇。高维加权基因共表达网络分析(hdWGCNA)确定了与γδT细胞相关的关键基因模块。大量RNA-seq分析也证明了免疫细胞的异质性,γδT-score与炎症反应呈正相关,与MYC干性呈负相关。筛选并验证了8个与γδT细胞相关的枢纽基因(GTRGs),包括ITGAE、IKZF3、LSP1、NEDD9、CLEC2D、RBPJ、TRBC2和OXNAD1,作为宫颈癌的预后特征:我们发现了与γδT细胞相关的预后特征,这些特征可被视为宫颈癌生存预测的独立因素。
{"title":"Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer.","authors":"Xiaochuan Wang, Yichao Jin, Liangheng Xu, Sizhen Tao, Yifei Wu, Chunping Ao","doi":"10.1177/10732748241274228","DOIUrl":"https://doi.org/10.1177/10732748241274228","url":null,"abstract":"<p><strong>Background: </strong>Gamma delta (γδ) T cells play dual roles in human tumors, with both antitumor and tumor-promoting functions. However, the role of γδT cells in HPV-infected cervical cancer is still undetermined. Therefore, we aimed to identify γδT cell-related prognostic signatures in the cervical tumor microenvironment.</p><p><strong>Methods: </strong>Single-cell RNA-sequencing (scRNA-seq) data, bulk RNA-seq data, and corresponding clinical information of cervical cancer patients were obtained from the TCGA and GEO databases. The Seurat R package was used for single-cell analysis, and machine learning algorithms were used to screen and construct a γδT cell-related prognostic signature. Real-time quantitative PCR (RT-qPCR) was performed to detect the expression of prognostic signature genes.</p><p><strong>Results: </strong>Single-cell analysis indicated distinct populations of γδT cells between HPV-positive (HPV+) and HPV-negative (HPV-) cervical cancers. A trajectory analysis indicated γδT cells clustered into differential clusters with the pseudotime. High-dimensional Weighted Gene Co-expression Network Analysis (hdWGCNA) identified the key γδT cell-related gene modules. Bulk RNA-seq analysis also demonstrated the heterogeneity of immune cells, and the γδT-score was positively associated with inflammatory response and negatively associated with MYC stemness. Eight γδT cell-related hub genes (GTRGs), including ITGAE, IKZF3, LSP1, NEDD9, CLEC2D, RBPJ, TRBC2, and OXNAD1, were selected and validated as a prognostic signature for cervical cancer.</p><p><strong>Conclusion: </strong>We identified γδT cell-related prognostic signatures that can be considered independent factors for survival prediction in cervical cancer.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142113872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interactions Between Oral Microbiota and Cancers in the Aging Community: A Narrative Review. 老年人口腔微生物群与癌症之间的相互作用:叙述性综述。
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241270553
Sara Aghili, Hussein Rahimi, Lotfollah Kamali Hakim, Shahryar Karami, Reza Sayyad Soufdoost, Asal Bagherzadeh Oskouei, Mostafa Alam, Ashkan Badkoobeh, Mohsen Golkar, Kamyar Abbasi, Artak Heboyan, Zahra Sadat Hosseini

The oral microbiome potentially wields significant influence in the development of cancer. Within the human oral cavity, an impressive diversity of more than 700 bacterial species resides, making it the second most varied microbiome in the body. This finely balanced oral microbiome ecosystem is vital for sustaining oral health. However, disruptions in this equilibrium, often brought about by dietary habits and inadequate oral hygiene, can result in various oral ailments like periodontitis, cavities, gingivitis, and even oral cancer. There is compelling evidence that the oral microbiome is linked to several types of cancer, including oral, pancreatic, colorectal, lung, gastric, and head and neck cancers. This review discussed the critical connections between cancer and members of the human oral microbiota. Extensive searches were conducted across the Web of Science, Scopus, and PubMed databases to provide an up-to-date overview of our understanding of the oral microbiota's role in various human cancers. By understanding the possible microbial origins of carcinogenesis, healthcare professionals can diagnose neoplastic diseases earlier and design treatments accordingly.

口腔微生物组可能对癌症的发展产生重大影响。在人类口腔中,存在着 700 多种细菌,其多样性令人印象深刻,是人体中微生物种类第二多的部位。这种微妙平衡的口腔微生物群生态系统对于维持口腔健康至关重要。然而,饮食习惯和口腔卫生不当往往会破坏这种平衡,从而导致各种口腔疾病,如牙周炎、龋齿、牙龈炎甚至口腔癌。有令人信服的证据表明,口腔微生物群与几种癌症有关,包括口腔癌、胰腺癌、结肠直肠癌、肺癌、胃癌和头颈癌。本综述讨论了癌症与人类口腔微生物群成员之间的重要联系。我们在 Web of Science、Scopus 和 PubMed 数据库中进行了广泛的搜索,以提供我们对口腔微生物群在各种人类癌症中所起作用的理解的最新概览。通过了解致癌的可能微生物起源,医疗保健专业人员可以更早地诊断肿瘤性疾病并设计相应的治疗方法。
{"title":"Interactions Between Oral Microbiota and Cancers in the Aging Community: A Narrative Review.","authors":"Sara Aghili, Hussein Rahimi, Lotfollah Kamali Hakim, Shahryar Karami, Reza Sayyad Soufdoost, Asal Bagherzadeh Oskouei, Mostafa Alam, Ashkan Badkoobeh, Mohsen Golkar, Kamyar Abbasi, Artak Heboyan, Zahra Sadat Hosseini","doi":"10.1177/10732748241270553","DOIUrl":"10.1177/10732748241270553","url":null,"abstract":"<p><p>The oral microbiome potentially wields significant influence in the development of cancer. Within the human oral cavity, an impressive diversity of more than 700 bacterial species resides, making it the second most varied microbiome in the body. This finely balanced oral microbiome ecosystem is vital for sustaining oral health. However, disruptions in this equilibrium, often brought about by dietary habits and inadequate oral hygiene, can result in various oral ailments like periodontitis, cavities, gingivitis, and even oral cancer. There is compelling evidence that the oral microbiome is linked to several types of cancer, including oral, pancreatic, colorectal, lung, gastric, and head and neck cancers. This review discussed the critical connections between cancer and members of the human oral microbiota. Extensive searches were conducted across the Web of Science, Scopus, and PubMed databases to provide an up-to-date overview of our understanding of the oral microbiota's role in various human cancers. By understanding the possible microbial origins of carcinogenesis, healthcare professionals can diagnose neoplastic diseases earlier and design treatments accordingly.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11378226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population. 土耳其卵巢癌患者全基因组修复基因多态性调查
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241270597
Sara Yaser Barham, Dorcas Omotade, Seda Yılmaz, Fatma Tuba Akdeniz, Betül Çapar Goralı, Rukset Attar, Turgay İsbir

Introduction: Ovarian cancer (OC) poses significant challenges due to its high mortality rate, particularly in advanced stages where symptoms may not be evident. DNA repair mechanisms, including nucleotide excision repair (NER), are crucial in maintaining genomic stability and preventing cancer. This study focuses on exploring the role of two NER-related genes, Xeroderma Pigmentosum Complementation Group C (XPC) and DNA Damage Binding Protein 2 (DDB2), in OC susceptibility.

Objectives: This study aims to investigate the association between variations in two NER-related genes, XPC rs2228001 and DDB2 rs830083, among a cohort of Turkish individuals with OC and control subjects.

Methods: Genotyping of XPC rs2228001 and DDB2 rs830083 was performed on 103 OC patients and 104 control subjects from the Turkish population using the Fast Real-Time 7500 PCR platform from Applied Biosystems.

Results: Individuals with the homozygous AA genotype of XPC rs2228001 exhibited a reduced likelihood of developing OC (OR 0.511; 95% CI 0.261 - 1.003; P-value 0.049), whereas those with the CC variant faced an elevated risk (OR = 2.32, 95% CI = 1.75-3.08; P-value 0.035). The presence of the A allele was associated with decreased OC occurrence (P-value = 0.035). Similarly, for DDB2 rs830083, individuals with the homozygous CG genotype had a diminished risk of OC (P-value 0.036), compared to those with the GG polymorphism (OR 1.895; 95% CI 1.033 - 3.476; P-value 0.038). Furthermore, the presence of the C allele was associated with a 1.89-fold decrease in the likelihood of OC.

Conclusion: These findings shed light on the genetic factors influencing OC susceptibility, emphasizing the importance of DNA repair systems in disease. Further research in larger and more diverse populations is warranted to validate these findings, facilitating precise risk assessment, and potentially guiding tailored treatment strategies for OC patients.

导言:卵巢癌(OC)的死亡率很高,尤其是在症状不明显的晚期,这给研究带来了巨大挑战。DNA 修复机制,包括核苷酸切除修复(NER),是维持基因组稳定性和预防癌症的关键。本研究主要探讨两个与 NER 相关的基因--色素沉着病补体 C 组(XPC)和 DNA 损伤结合蛋白 2(DDB2)在 OC 易感性中的作用:本研究旨在调查土耳其 OC 患者和对照组中两个 NER 相关基因(XPC rs2228001 和 DDB2 rs830083)变异之间的关联:使用应用生物系统公司的快速实时 7500 PCR 平台对土耳其人群中的 103 名 OC 患者和 104 名对照组受试者进行了 XPC rs2228001 和 DDB2 rs830083 的基因分型:结果:XPC rs2228001的同源AA基因型个体患OC的可能性降低(OR 0.511;95% CI 0.261 - 1.003;P值0.049),而CC变体个体的风险升高(OR = 2.32,95% CI = 1.75-3.08;P值0.035)。A 等位基因的存在与 OC 发生率的降低有关(P 值 = 0.035)。同样,就 DDB2 rs830083 而言,与 GG 多态性(OR 1.895;95% CI 1.033 - 3.476;P 值 0.038)的个体相比,同源 CG 基因型的个体发生 OC 的风险降低(P 值 0.036)。此外,C 等位基因的存在与发生 OC 的可能性降低 1.89 倍相关:这些发现揭示了影响 OC 易感性的遗传因素,强调了 DNA 修复系统在疾病中的重要性。为了验证这些发现,我们有必要在更大范围、更多样化的人群中开展进一步研究,以便进行精确的风险评估,并为 OC 患者量身定制治疗策略提供潜在指导。
{"title":"Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population.","authors":"Sara Yaser Barham, Dorcas Omotade, Seda Yılmaz, Fatma Tuba Akdeniz, Betül Çapar Goralı, Rukset Attar, Turgay İsbir","doi":"10.1177/10732748241270597","DOIUrl":"10.1177/10732748241270597","url":null,"abstract":"<p><strong>Introduction: </strong>Ovarian cancer (OC) poses significant challenges due to its high mortality rate, particularly in advanced stages where symptoms may not be evident. DNA repair mechanisms, including nucleotide excision repair (NER), are crucial in maintaining genomic stability and preventing cancer. This study focuses on exploring the role of two NER-related genes, Xeroderma Pigmentosum Complementation Group C (XPC) and DNA Damage Binding Protein 2 (DDB2), in OC susceptibility.</p><p><strong>Objectives: </strong>This study aims to investigate the association between variations in two NER-related genes, XPC rs2228001 and DDB2 rs830083, among a cohort of Turkish individuals with OC and control subjects.</p><p><strong>Methods: </strong>Genotyping of XPC rs2228001 and DDB2 rs830083 was performed on 103 OC patients and 104 control subjects from the Turkish population using the Fast Real-Time 7500 PCR platform from Applied Biosystems.</p><p><strong>Results: </strong>Individuals with the homozygous AA genotype of XPC rs2228001 exhibited a reduced likelihood of developing OC (OR 0.511; 95% CI 0.261 - 1.003; <i>P-value</i> 0.049), whereas those with the CC variant faced an elevated risk (OR = 2.32, 95% CI = 1.75-3.08; <i>P-value</i> 0.035). The presence of the A allele was associated with decreased OC occurrence (<i>P-value</i> = 0.035). Similarly, for DDB2 rs830083, individuals with the homozygous CG genotype had a diminished risk of OC (<i>P-value</i> 0.036), compared to those with the GG polymorphism (OR 1.895; 95% CI 1.033 - 3.476; <i>P-value</i> 0.038). Furthermore, the presence of the C allele was associated with a 1.89-fold decrease in the likelihood of OC.</p><p><strong>Conclusion: </strong>These findings shed light on the genetic factors influencing OC susceptibility, emphasizing the importance of DNA repair systems in disease. Further research in larger and more diverse populations is warranted to validate these findings, facilitating precise risk assessment, and potentially guiding tailored treatment strategies for OC patients.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11378165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advances in CAR-T Therapy. CAR-T 疗法的最新进展。
IF 2.5 4区 医学 Q3 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1177/10732748241263713
Meher Binte Ali

Chimeric antigen receptor T cell therapy is used to treat hematological malignancies which are refractory to standard therapy. It is a form of immunotherapy in which a patient's T cells are programmed to act against tumor cells. We discuss the process of manufacturing CAR-T cells, the common side effects of therapy, and the recent emerging risk of T-cell malignancies after treatment.

嵌合抗原受体 T 细胞疗法用于治疗对标准疗法难治的血液恶性肿瘤。它是一种免疫疗法,患者的 T 细胞经过编程后可对抗肿瘤细胞。我们将讨论 CAR-T 细胞的制造过程、治疗的常见副作用以及最近出现的治疗后 T 细胞恶性肿瘤的风险。
{"title":"Recent Advances in CAR-T Therapy.","authors":"Meher Binte Ali","doi":"10.1177/10732748241263713","DOIUrl":"10.1177/10732748241263713","url":null,"abstract":"<p><p>Chimeric antigen receptor T cell therapy is used to treat hematological malignancies which are refractory to standard therapy. It is a form of immunotherapy in which a patient's T cells are programmed to act against tumor cells. We discuss the process of manufacturing CAR-T cells, the common side effects of therapy, and the recent emerging risk of T-cell malignancies after treatment.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265231/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communication and Social Determinants of Cancer Preventive Behaviors in Adolescents From Low Socio-Economic Backgrounds in India: A Cross-Sectional Study. 印度社会经济背景较差青少年预防癌症行为的沟通和社会决定因素:一项横断面研究。
IF 2.6 4区 医学 Q3 Medicine Pub Date : 2024-01-01 DOI: 10.1177/10732748241255538
Dhriti Dhawan, Rachel McCloud, Ramya Pinnamaneni, Gaurav Arora, Rajashree Kadam, Anamika Dutt, Nandina Biswas-Ramchandran, K Viswanath

Purpose: Promoting cancer preventive behaviors among adolescents, especially those from lower socioeconomic backgrounds, is crucial due to the significant impact of health behaviors in adolescence on disease risk in adulthood. With India witnessing a rise in cancer incidence and mortality, adolescence becomes a pivotal stage for establishing healthy habits, emphasizing the need for early cancer prevention efforts.

Methods: This cross-sectional study used survey data from 2242 adolescents attending public schools of Mumbai, India. Multiple logistic regression was conducted to determine the associations between cancer preventive behaviors and: (1) the individual and social determinants of health, and (2) media exposure.

Findings: Merely 21.5% of the adolescents ate fruits and vegetables daily, 50% of the adolescents exercised 3 or more times a week, and 20% of the adolescents admitted having used tobacco and/or supari. Girls were found to have lower odds of exercising, as well as using tobacco and/or supari. Wealth and father's education were positively associated with all 3 cancer preventive behaviors. Media exposure was negatively associated, with television exposure linked to reduced fruits and vegetables consumption, while movies and social media exposure were associated with increased tobacco and/or supari use.

Interpretation: Our findings suggest that individual and social determinants of health and media exposure can influence cancer preventive health behaviors in low socio-economic status (SES) adolescents. Efforts to increase awareness to promote cancer preventive behaviors among the adolescents, particularly low SES adolescents, a population more vulnerable to poor health outcomes, is critical.

目的:促进青少年尤其是社会经济背景较差的青少年的癌症预防行为至关重要,因为青少年时期的健康行为对成年后的疾病风险有重大影响。随着印度癌症发病率和死亡率的上升,青春期成为建立健康生活习惯的关键阶段,强调了早期癌症预防工作的必要性:这项横断面研究使用了印度孟买公立学校 2242 名青少年的调查数据。方法:这项横断面研究使用了印度孟买公立学校 2242 名青少年的调查数据,并进行了多元逻辑回归,以确定癌症预防行为与以下因素之间的关联:(研究结果:只有 21.5%的青少年每天吃水果和蔬菜,50%的青少年每周锻炼 3 次或 3 次以上,20% 的青少年承认曾使用烟草和/或 supari。研究发现,女孩锻炼以及吸烟和/或吸食大麻的几率较低。财富和父亲的教育程度与这三种癌症预防行为都呈正相关。媒体接触呈负相关,电视接触与水果和蔬菜摄入量的减少有关,而电影和社交媒体接触与烟草和/或 supari 使用量的增加有关:我们的研究结果表明,健康的个人和社会决定因素以及媒体接触会影响社会经济地位较低的青少年的癌症预防健康行为。提高青少年,尤其是社会经济地位较低的青少年(这类人群更容易受到不良健康后果的影响)对促进癌症预防行为的认识至关重要。
{"title":"Communication and Social Determinants of Cancer Preventive Behaviors in Adolescents From Low Socio-Economic Backgrounds in India: A Cross-Sectional Study.","authors":"Dhriti Dhawan, Rachel McCloud, Ramya Pinnamaneni, Gaurav Arora, Rajashree Kadam, Anamika Dutt, Nandina Biswas-Ramchandran, K Viswanath","doi":"10.1177/10732748241255538","DOIUrl":"10.1177/10732748241255538","url":null,"abstract":"<p><strong>Purpose: </strong>Promoting cancer preventive behaviors among adolescents, especially those from lower socioeconomic backgrounds, is crucial due to the significant impact of health behaviors in adolescence on disease risk in adulthood. With India witnessing a rise in cancer incidence and mortality, adolescence becomes a pivotal stage for establishing healthy habits, emphasizing the need for early cancer prevention efforts.</p><p><strong>Methods: </strong>This cross-sectional study used survey data from 2242 adolescents attending public schools of Mumbai, India. Multiple logistic regression was conducted to determine the associations between cancer preventive behaviors and: (1) the individual and social determinants of health, and (2) media exposure.</p><p><strong>Findings: </strong>Merely 21.5% of the adolescents ate fruits and vegetables daily, 50% of the adolescents exercised 3 or more times a week, and 20% of the adolescents admitted having used tobacco and/or supari. Girls were found to have lower odds of exercising, as well as using tobacco and/or supari. Wealth and father's education were positively associated with all 3 cancer preventive behaviors. Media exposure was negatively associated, with television exposure linked to reduced fruits and vegetables consumption, while movies and social media exposure were associated with increased tobacco and/or supari use.</p><p><strong>Interpretation: </strong>Our findings suggest that individual and social determinants of health and media exposure can influence cancer preventive health behaviors in low socio-economic status (SES) adolescents. Efforts to increase awareness to promote cancer preventive behaviors among the adolescents, particularly low SES adolescents, a population more vulnerable to poor health outcomes, is critical.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11089949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1